The present work describes the development and following validation of a stability indicating reverse phase HPLC (RP-HPLC) method for the analysis of Empagliflozin in its API. The proposed method utilizes Hypersil BDS column Mobile phase 0.1% OPA: Acetonitrile in the ratio of 70:30 and flow rate was maintained at 1ml/min, detection wave length was 233nm, column temperature was set to 30oC . The developed method was successfully validated for different validation parameters as per ICH guidelines. The stability of the drug was determined by studying the degradation of the drug under acidic, alkaline, peroxide, neutral, heat and UV conditions.
